Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 1661-1670 Newer>

BusinessWeek January 17, 2005 Gene G. Marcial	Cornell May Be Poised For A Breakout There's unrest at Cornell, a provider of operational services, including medical treatment and education, to 70 federal and local prisons in 13 states.
The Motley Fool January 6, 2005 Stephen D. Simpson	Can Medtronic Still Quicken the Pulse? While increased competition looms for the medical device maker, a shareholder update looks to the past.
The Motley Fool January 6, 2005 Rich Duprey	Bristol-Myers Relieves Its Headache The pharmaceutical giant is selling its consumer medicines division. Though the division represents only about 2% of Bristol-Myers' $21 billion sales, the company overall has seen sales falter and its stock decline some 12% last year.
The Motley Fool January 5, 2005 Charly Travers	AstraZeneca's Lead Evaporates Pulling an application for Iressa from the EU makes the drug a has-been.
The Motley Fool January 5, 2005 Rich Duprey	Sharks Don't Go Blind Shark liver oil shows promise in treatment of age-related macular degeneration. Genaera Corp. though leading this interesting investigation, is not profitable, racking up some significant losses over the years.
The Motley Fool January 4, 2005 W.D. Crotty	A StemCell First News of an FDA application sends StemCells' stock soaring.
The Motley Fool January 4, 2005 Brian Gorman	Omnicare's Strange Buy Omnicare's expansion of its clinical research organization (CRO) unit seems unwise given its effort to acquire a major rival.
The Motley Fool January 4, 2005 Rich Smith	Blood for Sale Cord blood harvester ViaCell moves closer to its IPO, with pricing to be in the $7 to $9 range and will float 7.5 million shares, though still on a date "to be announced."
The Motley Fool January 4, 2005 Charly Travers	Cloning Fluffy Pet cloners like Genetic Savings & Clone (GSC) are clearly part of a new market on the verge of breaking open, and the opportunity for the first movers in this field is quite large. While private now, biotech investors need to keep watch.
Managed Care December 2004 Martin Sipkoff	A Better Case for Quality: Share the Savings! Brent James's research has led to a new and powerful vision of paying for performance that binds physicians, plans and hospitals together.
<Older 1661-1670 Newer> Return to current articles.